VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $314,195 | -61.2% | 33,532 | +1.6% | 0.00% | -100.0% |
| Q2 2023 | $809,392 | -2.1% | 32,996 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $826,969 | -13.4% | 35,538 | -5.8% | 0.00% | 0.0% |
| Q4 2022 | $955,149 | +17.2% | 37,738 | -10.7% | 0.00% | 0.0% |
| Q3 2022 | $815,197 | -30.7% | 42,282 | -8.5% | 0.00% | -66.7% |
| Q2 2022 | $1,177,000 | +93.0% | 46,215 | +94.8% | 0.00% | +200.0% |
| Q1 2022 | $610,000 | -37.0% | 23,719 | +2.6% | 0.00% | -50.0% |
| Q4 2021 | $968,000 | -4.9% | 23,122 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $1,018,000 | -9.3% | 23,393 | -1.4% | 0.00% | 0.0% |
| Q2 2021 | $1,122,000 | -6.7% | 23,734 | +1.1% | 0.00% | 0.0% |
| Q1 2021 | $1,203,000 | +92.8% | 23,469 | +0.7% | 0.00% | +100.0% |
| Q4 2020 | $624,000 | +0.2% | 23,306 | +28.4% | 0.00% | 0.0% |
| Q3 2020 | $623,000 | -5.0% | 18,148 | +13.3% | 0.00% | -50.0% |
| Q2 2020 | $656,000 | – | 16,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |